Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.150
-0.100 (-4.44%)
Aug 28, 2026, 4:10 PM AEST
Racura Oncology Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Other Revenue | 2.81 | 5.25 | 4 | 3.13 | 0.71 |
| 2.81 | 5.25 | 4 | 3.13 | 0.71 | |
Revenue Growth | -46.49% | 31.25% | 27.73% | 342.83% | 82.71% |
Cost of Revenue | 1.09 | 0.64 | 2.61 | 2.03 | 0.99 |
Gross Profit | 1.72 | 4.62 | 1.39 | 1.11 | -0.28 |
Selling, General & Admin | 3.28 | 3.28 | 3.79 | 3.04 | 4.33 |
Research & Development | 7.62 | 5.9 | 10.98 | 7.6 | 5.83 |
Amortization of Goodwill & Intangibles | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 |
Other Operating Expenses | 0.94 | 0.66 | 0.82 | 0.66 | 0.48 |
Operating Expenses | 12.12 | 10.12 | 15.87 | 11.58 | 10.92 |
Operating Income | -10.4 | -5.5 | -14.48 | -10.48 | -11.2 |
Interest & Investment Income | 0.61 | 0.79 | 0.83 | 0.59 | 0.05 |
Other Non Operating Income (Expenses) | -0.16 | -0.07 | -0.17 | -0.04 | -0.05 |
EBT Excluding Unusual Items | -9.95 | -4.79 | -13.82 | -9.92 | -11.2 |
Other Unusual Items | -1.14 | - | - | - | - |
Pretax Income | -11.09 | -4.79 | -13.82 | -9.92 | -11.2 |
Net Income | -11.09 | -4.79 | -13.82 | -9.92 | -11.2 |
Net Income to Common | -11.09 | -4.79 | -13.82 | -9.92 | -11.2 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 179 | 172 | 165 | 161 | 153 |
Shares Outstanding (Diluted) | 179 | 172 | 165 | 161 | 153 |
Shares Change | 3.90% | 4.81% | 2.35% | 4.83% | 17.06% |
EPS (Basic) | -0.06 | -0.03 | -0.08 | -0.06 | -0.07 |
EPS (Diluted) | -0.06 | -0.03 | -0.08 | -0.06 | -0.07 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -8.25 | -4.57 | -9.55 | -10.65 | -6.26 |
Free Cash Flow Per Share | -0.05 | -0.03 | -0.06 | -0.07 | -0.04 |
Gross Margin | 61.23% | 87.91% | 34.72% | 35.35% | -39.91% |
Operating Margin | -369.99% | -104.74% | -361.80% | -334.22% | -1582.76% |
Profit Margin | -394.38% | -91.11% | -345.18% | -316.60% | -1582.63% |
Free Cash Flow Margin | -293.44% | -87.06% | -238.43% | -339.83% | -884.12% |
EBITDA | -10.12 | -5.22 | -14.2 | -10.19 | -10.92 |
EBITDA Margin | - | -99.39% | - | - | - |
D&A For EBITDA | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 |
EBIT | -10.4 | -5.5 | -14.48 | -10.48 | -11.2 |
EBIT Margin | - | -104.74% | - | - | - |